These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 27388323)

  • 1. Mass spectrometric properties of N-(2-methoxybenzyl)-2-(2,4,6-trimethoxyphenyl)ethanamine (2,4,6-TMPEA-NBOMe), a new representative of designer drugs of NBOMe series and derivatives thereof.
    Shevyrin V; Kupriyanova O; Lebedev AT; Melkozerov V; Eltsov O; Shafran Y; Morzherin Y; Sadykova R
    J Mass Spectrom; 2016 Oct; 51(10):969-979. PubMed ID: 27388323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analytical characterization of three hallucinogenic N-(2-methoxy)benzyl derivatives of the 2C-series of phenethylamine drugs.
    Zuba D; Sekuła K
    Drug Test Anal; 2013 Aug; 5(8):634-45. PubMed ID: 22936468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analytical characterization of four new ortho-methoxybenzylated amphetamine-type designer drugs.
    Westphal F; Girreser U; Waldmüller D
    Drug Test Anal; 2016 Sep; 8(9):910-9. PubMed ID: 26606897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MS-Based Molecular Networking of Designer Drugs as an Approach for the Detection of Unknown Derivatives for Forensic and Doping Applications: A Case of NBOMe Derivatives.
    Yu JS; Seo H; Kim GB; Hong J; Yoo HH
    Anal Chem; 2019 May; 91(9):5483-5488. PubMed ID: 30990678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nano liquid chromatography-high-resolution mass spectrometry for the identification of metabolites of the two new psychoactive substances N-(ortho-methoxybenzyl)-3,4-dimethoxyamphetamine and N-(ortho-methoxybenzyl)-4-methylmethamphetamine.
    Caspar AT; Meyer MR; Westphal F; Weber AA; Maurer HH
    Talanta; 2018 Oct; 188():111-123. PubMed ID: 30029353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of five substituted phenethylamine derivatives 5-MAPDB, 5-AEDB, MDMA methylene homolog, 6-Br-MDMA, and 5-APB-NBOMe.
    Liu C; Jia W; Qian Z; Li T; Hua Z
    Drug Test Anal; 2017 Feb; 9(2):199-207. PubMed ID: 26856255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of hallucinogenic phenethylamines using high-resolution mass spectrometry for non-targeted screening purposes.
    Pasin D; Cawley A; Bidny S; Fu S
    Drug Test Anal; 2017 Oct; 9(10):1620-1629. PubMed ID: 28133938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthetic cannabinoid 3-benzyl-5-[1-(2-pyrrolidin-1-ylethyl)-1H-indol-3-yl]-1,2,4-oxadiazole. The first detection in illicit market of new psychoactive substances.
    Shevyrin V; Melkozerov V; Eltsov O; Shafran Y; Morzherin Y
    Forensic Sci Int; 2016 Feb; 259():95-100. PubMed ID: 26771874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-performance liquid chromatography tandem mass spectrometry method for the determination of 2CC-NBOMe and 25I-NBOMe in human serum.
    Poklis JL; Charles J; Wolf CE; Poklis A
    Biomed Chromatogr; 2013 Dec; 27(12):1794-800. PubMed ID: 23893863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gas Chromatography Mass Spectrometry (GC-MS) for Identification of Designer Stimulants Including 2C Amines, NBOMe Compounds, and Cathinones in Urine.
    Ketha H; Webb M; Clayton L; Li S
    Curr Protoc Toxicol; 2017 Nov; 74():4.43.1-4.43.10. PubMed ID: 29117432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of novel psychoactive substances 25B-NBOMe and 4-CMC in biological material using HPLC-Q-TOF-MS and their quantification in blood using UPLC-MS/MS in case of severe intoxications.
    Wiergowski M; Aszyk J; Kaliszan M; Wilczewska K; Anand JS; Kot-Wasik A; Jankowski Z
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Jan; 1041-1042():1-10. PubMed ID: 27992785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and determination of analytical characteristics and differentiation of positional isomers in the series of N-(2-methoxybenzyl)-2-(dimethoxyphenyl)ethanamine using chromatography-mass spectrometry.
    Kupriyanova OV; Shevyrin VA; Shafran YM; Lebedev AT; Milyukov VA; Rusinov VL
    Drug Test Anal; 2020 Aug; 12(8):1154-1170. PubMed ID: 32415729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and characterization of 2,5-dimethoxy-3,4-dimethyl-β-phenethylamine (2C-G)--a new designer drug.
    Zuba D; Sekuła K
    Drug Test Anal; 2013 Jul; 5(7):549-59. PubMed ID: 22927304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic fate and detectability of the new psychoactive substances 2-(4-bromo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine (25B-NBOMe) and 2-(4-chloro-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine (25C-NBOMe) in human and rat urine by GC-MS, LC-MS
    Caspar AT; Brandt SD; Stoever AE; Meyer MR; Maurer HH
    J Pharm Biomed Anal; 2017 Feb; 134():158-169. PubMed ID: 27915193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthetic cannabinoids as designer drugs: new representatives of indol-3-carboxylates series and indazole-3-carboxylates as novel group of cannabinoids. Identification and analytical data.
    Shevyrin V; Melkozerov V; Nevero A; Eltsov O; Baranovsky A; Shafran Y
    Forensic Sci Int; 2014 Nov; 244():263-75. PubMed ID: 25305529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure fragmentation studies of ring-substituted N-trifluoroacetyl-N-benzylphenethylamines related to the NBOMe drugs.
    Almalki AJ; Clark CR; DeRuiter J
    Rapid Commun Mass Spectrom; 2020 Feb; 34(4):e8593. PubMed ID: 31518025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 25C-NBOMe and 25I-NBOMe metabolite studies in human hepatocytes, in vivo mouse and human urine with high-resolution mass spectrometry.
    Wohlfarth A; Roman M; Andersson M; Kugelberg FC; Diao X; Carlier J; Eriksson C; Wu X; Konradsson P; Josefsson M; Huestis MA; Kronstrand R
    Drug Test Anal; 2017 May; 9(5):680-698. PubMed ID: 27448631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of 25I-NBOMe, 25B-NBOMe, 25C-NBOMe and Other Dimethoxyphenyl-N-[(2-Methoxyphenyl) Methyl]Ethanamine Derivatives on Blotter Paper.
    Poklis JL; Raso SA; Alford KN; Poklis A; Peace MR
    J Anal Toxicol; 2015 Oct; 39(8):617-23. PubMed ID: 26378135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurochemical pharmacology of psychoactive substituted N-benzylphenethylamines: High potency agonists at 5-HT
    Eshleman AJ; Wolfrum KM; Reed JF; Kim SO; Johnson RA; Janowsky A
    Biochem Pharmacol; 2018 Dec; 158():27-34. PubMed ID: 30261175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retrospective Demonstration of 25I-NBOMe Acute Poisoning Using Hair Analysis.
    Ameline A; Farrugia A; Raul JS; Kintz P
    Curr Pharm Biotechnol; 2017; 18(10):786-790. PubMed ID: 29189143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.